Company: MIRM
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001759425-25-000014
Chunk: 166

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 166
---
 includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Ernst & Young LLP

San Mateo, California

February 26, 2025

104

Table of Contents

Mirum Pharmaceuticals, Inc.

Consolidated Balance Sheets

(In thousands, except share and per share data)

 December 31, 20242023AssetsCurrent assets:Cash and cash equivalents$222,503 $286,326 Short-term investments57,812 — Accounts receivable78,286 67,968 Inventory22,403 22,312 Prepaid expenses and other current assets11,784 10,935 Total current assets392,788 387,541 Restricted cash425 — Long-term investments12,526 — Property and equipment, net1,139 706 Operating lease right-of-use assets8,675 1,284 Intangible assets, net249,819 252,925 Other assets5,382 4,165 Total assets$670,754 $646,621 Liabilities and Stockholders’ EquityCurrent liabilities:Accounts payable$14,618 $7,416 Accrued expenses110,224 78,544 Operating lease liabilities, current1,709 1,104 Total current liabilities126,551 87,064 Operating lease liabilities, noncurrent7,972 617 Convertible notes payable, net, noncurrent308,082 306,421 Other liabilities2,509 3,849 Total liabilities445,114 397,951 Commitments and contingenciesStockholders’ equity:Preferred stock, $